销售:
400-829-7929(7*24小时)
028-82633860
028-82633397
028-82633165
技术服务和产品定制:
028-82633987
在线服务:
沈帅
文静
贺丹丹
Seung Ho Baek, Chulwon Kim, Jong Hyun Lee,Dongwoo Nam, Junhee Lee, Seok-Geun Lee,Won-Seok Chung, Hyeung-Jin Jang, Sung-Hoon Kim & Kwang Seok Ahn
Cinobufagin (CBG) is a cardiotoxic bufanolide steroid secreted by the skin and parotid venom glands of the Asiatic toad Bufo bufo gargarizans (called Chan-Su). Although CBG is known to exhibit anti-cancer activities, very little is known about its potential mechanism(s) of action. In this study, we investigated whether CBG mediates its effect through the modulation of the mitogen-activated protein kinases (MAPKs) signaling pathway in human multiple myeloma (MM) U266 cells. We found that CBG caused the significant activation of ERK, JNK and p38 MAPK in U266 cells. CBG showed much higher cytotoxicity against U266 cells as compared to peripheral blood mononuclear cells (PBMC). Induction of CBG increased reactive oxygen species (ROS) generation from mitochondria, which is associated with the induction of apoptosis as characterized by increased sub-G1 DNA contents of cell cycle, positive Annexin V binding, activation of caspase-3 and cleavage of PARP. Inhibition of ROS generation by N-acetyl-l-cysteine (NAC) significantly prevented CBG-induced ERK, JNK and p38 MAPK activation and apoptosis. CBG also down-regulated the expression of various
Cinobufagin (CBG), with a purity greater than 99%, was purchased from Chengdu Biopurify
Phytochemicals Ltd. (Sichuan, China)